Profile
Paul van Slyke served as the Chief Scientific Officer at Vasomune Therapeutics, Inc. and Sairiyo Therapeutics, Inc. He also held the position of Chief Scientific Officer at Pharmadrug, Inc. from 2021 to 2023.
Dr. van Slyke obtained a doctorate degree from the University of Toronto.
Former positions of Paul van Slyke
| Companies | Position | End |
|---|---|---|
| PHARMADRUG INC. | Chief Tech/Sci/R&D Officer | 01/05/2023 |
Sairiyo Therapeutics, Inc.
 Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Chief Tech/Sci/R&D Officer | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | - |
Training of Paul van Slyke
| University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMADRUG INC. | Health Technology |
| Private companies | 2 |
|---|---|
Sairiyo Therapeutics, Inc.
Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Health Technology |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Paul van Slyke
